Statistics

Total Visits

Views
Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study21

Select a period of time:

Number of views in the range

Views
Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study8

Views

Views
May 20242
June 20241
July 20242
August 20240
September 20242
October 20240
November 20241
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States6
United Kingdom2
 

Top cities views

Views
Chicago3
Fort Worth1
Prineville1